← Leaderboards
Bianca Denise Santomasso
Sloan-Kettering Inst Can Research
$1,262,391
Attributed
$1,262,391
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $652.2K · FY2024–25$1M$750K$500K$250K$0
'24
'25
Funding mix
By agency
NIH$1,262,391 · 1
By mechanism
R01$1,262,391 · 1
Top collaborators
No co-investigators on record.
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Kojo Seys Elenitoba-Johnson$15,478,914
- Taha Merghoub$4,342,237
- Kayvan R Keshari$12,246,491
- Megan S. Lim$4,964,836
- Xiang Zhang$12,735,442
Others in their field
Other Rising Stars on “Acute”
- Taleen Hanania · Psychogenics, Inc.$9,482,040
- Gregory Sorenson · University Of Maryland Baltimore County$9,161,697
- Christopher J. Lindsell · Vanderbilt University Medical Center$8,536,327
- Michael E. Roth · Public Health Institute$8,201,777
- Jacob Sutton Coverstone · Neurovations$6,882,205
- Agustin G Yip · Albert Einstein College Of Medicine$6,090,308
Research focus
AcuteAdultAdrenal Cortex HormonesAnakinraAnisotropyAntagonistAnti-Cancer ResearchAgonistAttentionBiobankBioinformaticsBiometryBloodBrainCar T Cell TherapyCellsCerebrospinal FluidAphasiaChimeric Antigen Receptor T CellsChronicClinical Decision-MakingClinical ManagementComaCytokine
Grant awards (2)
Comprehensive Molecular and Clinical Characterization of Acute and Chronic Neurotoxicity Following CAR-T Cell Therapy$652,194
R01 · FY2025 · CA · contact PI
Comprehensive Molecular and Clinical Characterization of Acute and Chronic Neurotoxicity Following CAR-T Cell Therapy$610,197
R01 · FY2024 · CA · contact PI